Model results are only as good as the data fed as input or used for calibration. Data reconciliation for wastewater treatment modeling is a demanding task, and standardized approaches are lacking. This paper suggests a procedure to obtain high-quality data sets for model-based studies. The proposed approach starts with the collection of existing historical data, followed by the planning of additional measurements for reliability checks, a data reconciliation step, and it ends with an intensive measuring campaign. With the suggested method, it should be possible to detect, isolate, and finally identify systematic measurement errors leading to verified and qualitative data sets. To allow mass balances to be calculated or other reliability checks to be applied, few additional measurements must be introduced in addition to routine measurements. The intensive measurement campaign should be started only after all mass balances applied to the historical data are closed or the faults have been detected, isolated, and identified. In addition to the procedure itself, an overview of typical sources of errors is given.

Download full-text PDF

Source
http://dx.doi.org/10.2175/106143009x12529484815511DOI Listing

Publication Analysis

Top Keywords

data reconciliation
12
data
9
reconciliation wastewater
8
wastewater treatment
8
high-quality data
8
typical sources
8
sources errors
8
data sets
8
historical data
8
additional measurements
8

Similar Publications

Current state of APPE-readiness assessments in schools or colleges of pharmacy.

Curr Pharm Teach Learn

December 2024

Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, 410 North 12th Street, Richmond, VA 23298, United States of America. Electronic address:

Objective: To determine components and assessments included in Advanced Pharmacy Practice Experience (APPE) readiness plans in United States Doctor of Pharmacy (PharmD) programs.

Methods: An electronic survey was emailed to the American Association of Colleges of Pharmacy Laboratory Instructors Special Interest Group. Survey items included demographic information about the program, APPE-readiness plan implementation status and components.

View Article and Find Full Text PDF

The COVID-19 pandemic has highlighted the prevalence of fatigue, reduced interpersonal interaction, and heightened stress in work environments. The intersection of neuroscience and architecture underscores how intricate spatial perceptions are shaped by multisensory stimuli, profoundly influencing workers' wellbeing. In this study, EEG and VR technologies, specifically the , were employed to gather data on perception and cognition.

View Article and Find Full Text PDF

Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment.

Eur J Hosp Pharm

December 2024

Clinical Pharmacology and Pharmacy, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands

Background: The use of complementary and alternative medications (CAM) is popular among cancer patients. CAM includes vitamins, minerals, phytotherapy, homeopathy, nutritional supplements and probiotics. CAM use may lead to unwanted risks by interacting with anticancer drugs; therefore, it is important for healthcare providers to be aware of CAM use by their patients.

View Article and Find Full Text PDF

Background: High-quality estimates of the epidemiology of the autism spectrum and the health needs of autistic people are necessary for service planners and resource allocators. Here we present the global prevalence and health burden of autism spectrum disorder from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 following improvements to the epidemiological data and burden estimation methods.

Methods: For GBD 2021, a systematic literature review involving searches in PubMed, Embase, PsycINFO, the Global Health Data Exchange, and consultation with experts identified data on the epidemiology of autism spectrum disorder.

View Article and Find Full Text PDF

Background: Vascular surgery patients are at a high risk of polypharmacy and drug-related problems. Only a limited number of studies have explored the impact of hospital pharmacists being members of a multidisciplinary team in the care of vascular surgery patients. The clinical study (Trial Registration Number NCT04930302, 16 June 2021) aimed to assess the impact of pharmacist-led interventions on the prevalence of drug-related problems among patients hospitalised at the vascular surgery department.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!